Peter Svennilson, Director, 10% Owner at RAPT Therapeutics, Inc. (RAPT), sold 608,000 shares at $30.85 ($18.8M) on 2020-09-22, disclosed to the SEC on 2020-09-22.
Open-market sale of $18.8M RAPT by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NGM | BUY | 2022-06-06 | $877K | — | Filing → |
| NGM | BUY | 2022-05-19 | $4.0M | — | Filing → |
| RAPT | SELL | 2021-08-24 | $5.4M | — | Filing → |